NR3C1 and breast carcinoma: Our results suggest that in ER+ breast cancers, the status of the GR gene, as reflected by promoter methylation, may define a previously uncharacterized subset of patients and that GR methylation status plays an important role in determining the response to treatment and ultimately determines the prognosis of some of these patients.